Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • NeuroSciences Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Saudi Medical Journal
  • Other Publications
    • NeuroSciences Journal
  • My alerts
  • Log in
Saudi Medical Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
LetterCorrespondence
Open Access

Is there a low prevalence of Helicobacter pylori infection in Jordanian patients with gastric cancer?

Rinaldo Pellicano
Saudi Medical Journal December 2017, 38 (12) 1265-1266; DOI: https://doi.org/10.15537/smj.2017.12.21309
Rinaldo Pellicano
Unit of Gastroenterology Molinette Hospital Turin, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

To the Editor

Awad et al1 have explored the epidemiologic features of Jordanian patients with diagnosis of gastric cancer (GC) in the period January 2006 to May 2016. A total of 165 patients were included. Regarding tumor types, most of gastric malignancies were primary adenocarcinomas (62%). Regarding Helicobacter pylori (H.pylori) infection, in 129 cases, the presence of the bacterium could be assessed, with a prevalence of 49.6%. Intestinal-type and signet ring adenocarcinomas showed a prevalence of H. pylori infection of 55.6% and 48.8%, respectively.1 Helicobacter pylori is a slow-growing, micro-aerophilic, Gram-negative bacterium, usually acquired during childhood, whose natural habitat is the luminal surface of the gastric epithelium.2 Although in 1994 the International Agency for Research on Cancer classified H. pylori as a group I carcinogen, namely, a definite cause of GC, to date the bacterium is recognized as a necessary but insufficient cause of GC. This is due to the fact that such a malignancy is a complex, multifactorial disease caused by initiators and other continuator agents. Helicobacter pylori causes chronic gastric inflammation that may progress to the precancerous changes of atrophic gastritis and intestinal metaplasia.2

Several epidemiologic studies have approached the study of the relationship between H. pylori and GC. In a multicentre study, conducted in Northern Italy, we have shown that 82.3% of patients with GC versus 56.5% of controls (p<0.0001; odds ratio, 3.58; 95% confidence interval: 2.53-5.07) were seropositive for anti-H. pylori. There was no difference between intestinal-type and diffuse-type carcinoma.3 This high prevalence rate is similar to those reported by several studies.4 Considering that in Jordan previous studies have found a prevalence of H. pylori of approximately 80% in patients with dyspepsia and gastritis or peptic ulcer5 it is unexpected the low prevalence described by Awad et al in case of GC.1 It would be interesting to know how the authors could explain these differences. This would enrich their interesting findings.

Reply from the Author

I would like to thank Dr Pellicano for his interesting and valuable comments and queries. Our study demonstrated that 55.6% of intestinal type and 48.8% of signet ring gastric adenocarcinomas contained Helicobacter pylori (H. pylori).1 As Pellicano et al pointed out this prevalence is less than the 80% rate of H. pylori infection in Jordanian patients reported by Bani Hani et al.6 Our rate is also less than the prevalence reported by Latif et al7 who found that 70% of Jordanian patients with acute gastritis and 73% with chronic gastritis had H. pylori. One reason for this discrepancy is the method used to detect H. pylori. We relied on hematoxylin and eosin stained slides for their detection, whereas Bani Hani et al6 used modified Giemsa stain and Latif et al7 used bacteriology as well as histological studies; these 2 methods would have increased the detection rate. However, we believe that the main reason for the discrepancy is that the population in these studies are different. Our patients had gastric cancer, some with advanced disease, whereas none of the patients in the above mentioned studies had gastric carcinoma; they suffered from gastritis or gastric or duodenal ulceration. Helicobacter pylori associated gastritis predisposes to gastric cancer through a multistep process that includes gastric atrophy and intestinal metaplasia but it is well known that during this process H. pylori disappear because atrophy and intestinal metaplasia create an unfavorable environment for H. pylori.8 Within the population of our study the prevalence of intestinal metaplasia was 34.6%, this is possibly an underestimate because sampling of the patients’ specimens was not aimed at detecting metaplasia but at detecting cancer and its stage. The 34.6% rate quoted in the study is the rate of incidentally found intestinal metaplasia foci.

In summary we do not believe that the prevalence of H. pylori infection in gastric carcinoma among Jordanian patients is low. There are limitations in our study regarding detecting the actual prevalence of H. pylori due to the methodology used but also it is important to recognize that the demonstration of H. pylori after cancer development does not reflect the actual prevalence as this bacterium is expected to disappear once cancer has fully developed.

Heyam Awad

University of Jordan Jordan University Hospital Amman, Jordan

Student Corner

We invite students from a variety of medical disciplines to submit original contributions based on their supervised research.

The Student Corner of Saudi Med J aims to help students explore research opportunities and network with other peers and mentors in the same field.

Submission Guidelines

Submitted Abstracts should include the following:

  • Title should be descriptive

  • Author’s names and affiliation(specify college level/year, academic degree of Senior Author)

  • Abstract must be structured and not more than 300 words

  • The following are the typical headings:

Objectives (background, why the study was done, specific aims)

Methods (setting, date of study, design, subjects, intervention and analysis)

Results (findings, data and statistical tests) and

Conclusion (general interpretation of results)

General Information on Abstract Submission

Submitted Abstracts should be co-authored by a Senior Supervisor

Abstracts will be reviewed by Student’s Corner Section Editor

There is no fee to submit an Abstract

Ethical Approval should be provided

Non-indexed materials

  • Copyright: © Saudi Medical Journal

This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial License (CC BY-NC), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

References

  1. ↵
    1. Awad HA,
    2. Hajeer MH,
    3. Abulihya MW,
    4. Al-Chalabi MA,
    5. Al Khader AA
    (2017) Epidemiologic characteristics of gastric malignancies among Jordan university hospital patients. Saudi Med J 38:965–967.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Pellicano R,
    2. Ribaldone DG,
    3. Fagoonee S,
    4. Astegiano M,
    5. Saracco G,
    6. Mégraud F
    (2016) A 2016 panorama of Helicobacter pylori infection: key messages for clinicians. Panminerva Med 58:304–317.
    OpenUrl
  3. ↵
    1. Palestro G,
    2. Pellicano R,
    3. Fronda GR,
    4. Valente G,
    5. De Giuli M,
    6. Soldati T,
    7. et al.
    (2005) Prevalence of Helicobacter pylori infection and intestinal metaplasia in subjects who had undergone surgery for gastric adenocarcinoma in Northwest Italy. World J Gastroenterol 11:7131–7135.
    OpenUrlPubMed
  4. ↵
    1. Gonzalez CA,
    2. Mégraud F,
    3. Buissoniere A,
    4. et al.
    (2012) Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project. Ann Oncol 23:1320–1324.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Bani-Hani KE,
    2. Hammouri SM
    (2001) Prevalence of Helicobacter pylori in Northern Jordan. Endoscopy based study. Saudi Med J 22:843–847.
    OpenUrlPubMed
  6. ↵
    1. Bani-Hani KE,
    2. Hammouri SM
    (2001) Prevalence of Helicobacter pylori in Northern Jordan. Endoscopy based study. Saudi Med J 22:843–847.
    OpenUrlPubMed
  7. ↵
    1. Latif AH,
    2. Shami SK,
    3. Batchoun R,
    4. Murad N,
    5. Sartawi O
    (1991) Helicobacter pylori: a Jordanian study. Postgrad Med J 67:994–998.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Correa P,
    2. Blanca Piazuelo M
    (2017) Helicobacter pylori infection and gastric adenocarcinoma. US Gastroenterol Hepatol Rev 7:59–64.
    OpenUrl
PreviousNext
Back to top

In this issue

Saudi Medical Journal: 38 (12)
Saudi Medical Journal
Vol. 38, Issue 12
1 Dec 2017
  • Table of Contents
  • Cover (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Saudi Medical Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Is there a low prevalence of Helicobacter pylori infection in Jordanian patients with gastric cancer?
(Your Name) has sent you a message from Saudi Medical Journal
(Your Name) thought you would like to see the Saudi Medical Journal web site.
Citation Tools
Is there a low prevalence of Helicobacter pylori infection in Jordanian patients with gastric cancer?
Rinaldo Pellicano
Saudi Medical Journal Dec 2017, 38 (12) 1265-1266; DOI: 10.15537/smj.2017.12.21309

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Is there a low prevalence of Helicobacter pylori infection in Jordanian patients with gastric cancer?
Rinaldo Pellicano
Saudi Medical Journal Dec 2017, 38 (12) 1265-1266; DOI: 10.15537/smj.2017.12.21309
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • References
  • eLetters
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Management of trigger finger (stenosing tenosynovitis)
  • Comment on: Post surgical hypoparathyroidism
  • Overcoming socioeconomic obstacles is important in achieving equity in health care
Show more Correspondence

Similar Articles

CONTENT

  • home

JOURNAL

  • home

AUTHORS

  • home
Saudi Medical Journal

© 2025 Saudi Medical Journal Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.

Powered by HighWire